TheStreet Ratings

10 Best Managed-Healthcare Stocks for 2016 - TheStreet Ratings

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 managed-health care providers are rated highest by our value-focused stock rating model.

Equity Top: Managed Health Care


Source: TheStreet Ratings

Best Investments for

Healthcare Providers

By Emily Stewart
What the CBO had to say.
6/27/17 12:05AM
By Keris Alison Lahiff
Stocks mostly higher as indexes enter final week of first half.
6/26/17 7:11PM
By Keris Alison Lahiff
Stocks mostly higher as crude bounces back.
6/26/17 3:14PM
By Emily Stewart
Just days after releasing their first draft, Senate Republicans issued a revised version of their bill to repeal and replace Obamacare.
6/26/17 1:45PM
By Anders Keitz
American Water Works leads the S&P 500 for the most female representation on its board. But, there are still a handful of companies without any female directors.
6/26/17 12:17PM
By Keris Alison Lahiff
Stocks mixed as tech sector climbs.
6/26/17 10:53AM
By Scott Gamm
If healthcare reform fails to come to fruition, the stock market could be in for a pullback.
6/26/17 10:26AM
By TheStreet Staff
Don't go into everyone's favorite debate unprepared.
6/26/17 9:44AM
By ETFChannel.com
In recent trading, shares of Health Insurance Innovations, Inc have crossed above the average analyst 12-month target price of $25.33, changing hands for $25.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
6/26/17 9:16AM
By Keris Alison Lahiff
Futures higher as the healthcare sector climbs.
6/26/17 8:40AM
By Doug Kass
Doug Kass shares his thoughts on the market, and offers up some especially deep thoughts.
6/26/17 1:00AM
By William McConnell
To ensure passage, Mitch McConnell will have to navigate a treacherous obstacle while the clock is ticking.
6/24/17 4:20PM
By Kinsey Grant
Samsung's Bioepis unit seeks final approval in Europe of a rheumatoid arthritis drug to compete with Humira.
6/23/17 9:20PM
By Jim Cramer
Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.
6/23/17 9:00PM
By William McConnell
The agency faces a July 7 deadline but the two sitting commissioners are expected to want the decision before the July 4 holiday.
6/23/17 4:12PM

CHECK OUT OUR BEST SERVICES FOR INVESTORS

REAL MONEY

Jim Cramer and 30+ Wall Street professionals provide actionable guidance ranging from technical analysis to momentum trading and fundamental stock picking. Every trading day, Real Money offers a wealth of insight, analysis and strategies for all styles of investing.

Product Features:

  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums

14 Days Free
TRY IT NOW